Neuphoria Therapeutics Inc.
NEUP
Kedudukan dalam Saham
#29271
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Harga Saham
$3.92
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$21.16M
Perubahan (1 hari)
-0.13%
Perubahan (1 tahun)
60,767.52%
Negara
US
Perdagangan Neuphoria Therapeutics Inc. (NEUP)
Kategori
Healthcare
Modal pasaran bagi Neuphoria Therapeutics Inc.(NEUP)
Modal Pasaran: $21.16M
Sehingga October 2026, Neuphoria Therapeutics Inc. mempunyai modal pasaran sebanyak $21.16M. Ini menjadikan Neuphoria Therapeutics Inc. syarikat ke-29271st paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Neuphoria Therapeutics Inc. dari 1999 hingga 2026
NEUP berbanding dengan 5 teratas yang paling popular stocks
